Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE: Ipilimumab + Carboplatin/Etoposide in SCLC
NCT01331525Phase 2Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Jun 2011
- Primary completion
- Jun 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab in small cell lung cancer (SCLC), sponsored by University Hospital Southampton NHS Foundation Trust. Started Jun 2011; status: completed.
02
Drugs
ipilimumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01331525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01331525.